Automated Cryo-EM Sample Preparation Instrument
Archived on October 8, 2025. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EDT
- Posted
- September 19, 2025
- Notice type
- Combined Synopsis/Solicitation
- Set-aside
- No Set aside used
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesOFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION (ASA)
Notice details
- Office
- PROGRAM SUPPORT CENTER ACQ MGMT SVC
- Place of performance
- Bethesda, Maryland, 20814
- Last updated
- Nov 8, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75P00125Q00071
- Notice ID
- 4692107b47a94dc98b103a5f87e3c7c6
Description
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75P00125Q00071 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold.
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institute of Allergy and Infectious Diseases (NIAID), Office of Acquisition (OA), on behalf of the National Institutes of Health, intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to SPT Labtech Ltd, Melbourn Science Park, Melbourn, Hertfordshire for a Chameleon Cryo-EM Sample Preparation Instrument and Accessories.
This acquisition is conducted on a brand-name sole source basis pursuant to FAR 13.106-1(b)(1) under the Simplified Acquisition Procedures. The statutory authority is 41 USC 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source (Brand Name). The Sole Source Justification prepared in accordance with HHSAM 313.106-1(b)(1)(i) is attached.
The rationale for the brand-name justification is that the Chameleon Cryo-EM Sample Preparation Instrument is a unique tool that employs blot-free technology for sample preparation. Its self-wicking grids enable rapid, on-the-fly sample dispensing, minimizing the adverse effects of protein exposure to the air-water interface. This approach effectively addresses issues such as preferred orientation, aggregation, and denaturation. The instrument offers several key advantages, including the ability to dispense nanomolar sample volumes, automated grid handling, camera-assisted screening, experimental condition tracking and recording, and the development of automated workflows. Currently, no alternative equipment on the market utilizes blot-free technology.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-05, with effective date 8/7/2025.
(iv) The associated NAICS code is 334516 and the small business size standard is 1,000 employees. This requirement is full and open with no set-aside restrictions.
(v) This requirement is for the following items:
- Qty (1) - Chameleon Cryo-EM Sample Preparation Instrument
- Qty (2) - Chameleon Cryogen Bowl Assembly
- Qty (1) - Ethane Condensing Kit
- Qty (1) - Chameleon in-built Desktop PC Controller (Win10) with Chameleon Software License & Comms Installed
- Qty(1) - Chameleon Consumables Starter Pack Includes:
- 4150-40001 - pack of 50
- 4150-40003
- 4150-40004
- 4150-40005 - pack of 50
- 4150-40010
- Types Each
- 4150-40011
- NPN Source Bottles (Working Fluid Bottle and Waste)
- Qty (1) - Chameleon Installation
- Qty (1) - Vision lite - Chameleon Applications Support Package
Salient Characteristics:
- Minimum Sample Volume: 5μL Minimum Dispense Volume: 6nL
- Batch Capacity: 8 Grids
- Sample Temperature Control: 4°C to 40°C Minimum Dispense-to-Plunge Time: 54 msec Liquid Nitrogen Level Monitoring
- Liquid Ethane Temperature Control
- Integrated Semi-Automated Characterization and Plunge Speed Tuning
- Integrated Closed Loop Glow Discharge Module Integrated Post-Dispense QC System
- Session Tracking and Reporting Datapack
(vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition. The anticipated delivery is within thirty (30) days after receipt of order (ARO).. Delivery will be f.o.b. destination. The place of delivery and acceptance will be Building 40, Room 4609B, 40 Convent Drive, Bethesda MD, 20814.
Warranty coverage shall extend for 12 months from installation, through August 2026.
(vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html
(End of provision)
The following provisions apply to this acquisition and are incorporated by reference:
- FAR 52.204-7, System for Award Management (Nov 2024)
- FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)
- FAR 52.212-1, Instructions to Offerors—Commercial Products and Commercial Services (Sep 2023)
- FAR 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (May 2024)
- FAR 52.225-6, Trade Agreements Certificate (Feb 2021)
- HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015)
The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses:
https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html
(End of clause)
The following clauses apply to this acquisition and are incorporated by reference:
- FAR 52.204-13, System for Award Management Maintenance (Oct 2018)
- FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)
- FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2023).
- HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015)
- HHSAR 352.239-75, Information and Information Systems Security (Dec 2015)
The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal.
- FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment
- FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation
- FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Jan 2025)
The FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items (Jan 2025), applies to this acquisition and is provided in full text as Attachment #2.
- NIH Invoice and Payment Provisions
(viii) The provision at FAR clause 52.212-2, Evaluation-Commercial Items (Nov 2021), applies to this acquisition.
(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government. As this requirement will be awarded on a sole source basis to SPT Labtech Ltd., evaluation will be limited to verifying the product meets the stated technical requirements and determining that the proposed price is fair and reasonable in accordance with FAR 13.106-3.
(b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.
(ix) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (May 2024), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer.
(x) The clause at FAR 52.212-4, Contract Terms and Conditions—Commercial Products and Commercial Services (Nov 2023), applies to this acquisition.
(xi) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. The contractor shall provide warranty coverage for 12 months from installation, including replacement of any defective component that fails due to faulty manufacture or design defects.
(xii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.
(xiii) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations.
Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order.
The UEI (Unique Entity Identifier), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All quotations must be received by 12:00 p.m., Eastern Standard Time, on September 23, 2025 and reference Solicitation Number 75P00125Q00071. Responses must be submitted electronically to Eric McKay, Contract Specialist at eric.mckay@hhs.gov.
Fax responses will not be accepted.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Secondary Contact
Documents
Files (6)
- Download
Attachment 6 - SPT LabTech - SSJ Rev 1.pdf
295 KBAdded in Combined Synopsis/Solicitation version 3Posted - Download
Attachment 2 - SPT Labtech FAR 52.212-5.pdf
3.6 MBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 3 - FAR 52.212-4.pdf
1.2 MBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 1 - SPT Labtech Purchase Description_Final.pdf
131 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 5- Invoicing Instructions.pdf
389 KBAdded in Combined Synopsis/Solicitation version 1Posted - Download
Attachment 4 - FAR 52.204-24_52.204-26 Certs.pdf
184 KBAdded in Combined Synopsis/Solicitation version 1Posted
Lifecycle
- 1Version 1Combined Synopsis/SolicitationArchived
Automated Cryo-EM Sample Preparation Instrument
- 3Version 3Combined Synopsis/SolicitationArchivedCurrent
Automated Cryo-EM Sample Preparation Instrument
Other notices for this solicitation
- Market ResearchRelated noticeSep 17, 2025
Automated Cryo-EM Sample Preparation Instrument
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Illumina, Inc. Acquisition Description: The purpose of this acquisition is to purchase two Illumina MiSeq i100 series instruments. These instruments will be used by the NIH HLA Laboratory to produce high resolution HLA typing results for the numerous transplant protocols supported by the laboratory. It will replace the current Illumina MiSeq instruments in the lab that were purchased in 2021 and 2022. The vendor will discontinue service on the current model of the MiSeq. New instruments are required to ensure time to validate these replacements before discontinuation of service. The total dollar value for this order is $139,100.52. The MiSeq is an integrated instrument that performs clonal amplification, genomic DNA sequencing, and data analysis with base calling, alignment, variant calling, and reporting in a single run. The MiSeq provides the Lab with the highest HLA typing results possible. The transplant protocols served by the HLA Lab require highest resolution possible to increase the chance of a successful transplant. The HLA Lab currently owns two MiSeq instruments, so the procedures and Quality Control assessments are in place. The order aims to replace the Illumina Miseq – s/n M07700 (property ID is 02223449) and s/n M08636 (property ID is 02268689) that were purchased in 2019 and 2022. Replacement is necessary to ensure proper performance of these instruments prior to discontinuation of service for the current model of the Illumina MiSeq instruments by the vendor. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000836) by 12:00 PM eastern standard time on 11/27/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | - | Pre-Solicitation | 11/27/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00038 /PCA-NIA-11810. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. | - | Combined Synopsis | 12/08/2026 |
NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Hidex 600SLe Liquid Scintillation Counter (i) This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00033 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial product or commercial service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Office of Acquisition and Logistics Management (OALM), on behalf of the NIH Office of Research Services (ORS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) for the purchase of a Hidex 600SLe Liquid Scintillation Counter. The anticipated award date is 10/30/2026. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2026-01, with effective date 03/13/2026. (iv) The associated NAICS code is 334516 and the small business size standard is 1000 employees. (v) The Contractor shall provide the following Hidex brand equipment: 600 SLe LSC with MikroWin. Catalog Number: AH-20XX-09. Quantity: 1. Alpha/Beta Separation for 300/600SL. Catalog Number: AH-NXX-04. Quantity: 1. Eu-152 External Standard. Catalog Number: AH-NXX-13. Quantity: 1. Windows 11 Desktop PC with Monitor. Catalog Number: P3G-36XX-01. Quantity: 1. Installation and Training. Catalog Number: GL-Z1XX-24. Quantity: 1. Shipping Contractor must also provide pricing for a trade-in discount. NIH will be trading in two old pieces of equipment in this acquisition. (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated delivery date is 6-8 weeks ARO. (vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html https://www.acquisition.gov/caac-letters (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Nov 2024) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.204-29, Federal Acquisition Supply Chain Security Act Orders – Representation and Disclosures (Dec 2023) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Sep 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) (DEVIATION Feb 2025) CAAC_Letter_2025-01_Supplement-1.pdf and CAAC_Letter_2025-02_Supplement-1.pdf FAR 52.222-52, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Certification (May 2014) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html https://www.acquisition.gov/caac-letters (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services (Nov 2023). The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions below and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services ( Jan 2025) (DEVIATION Feb 2025) Per CAAC Letters 2025-01 and 2025-02, FAR 52.222-21, Prohibition of Segregated Facilities and FAR 52.222-26 - Equal Opportunity will not be considered when making award decisions or enforce requirements. FAR 52.222-52 Exemption from Application of the Service Contract Labor Standards to Contracts for Certain Services-Certification (May 2014). HHSAR 352.239-78, Information and Communication Technology Accessibility Notice (Feb 2024) (DEVIATION). HHSAR 352.239-79, Information and Communication Technology Accessibility (Feb 2024) (DEVIATION). FAR DEVIATION STATEMENT: The CAAC Letter 2025-01 -Supplement 1 and CAAC Letter 2025-02-Supplement 1 are applicable to this acquisition. System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations. Examples include 52.222-25, Affirmative Action Compliance, and paragraph (d) of 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services. Contracting officers will not consider these representations when making award decisions or enforce requirements. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM. The mentioned CAAC Letters may be accessed electronically at this address: CAAC Letters | Acquisition.GOV. The following invoice instruction is included and will be incorporated in the final award: NIH Invoicing Instructions with IPP (Mar 2023). (viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Products and Commercial Services (Nov 2021), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation is the lowest-priced technically-acceptable. (c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (ix) Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) (DEVIATION Feb 2025), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. See DEVIATION STATEMENT above regarding applicable CAAC Letters. (x) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices. There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xii) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the product selected as compared with that of a comparable product, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 12:00p.m., Eastern Standard Time, on October 29, 2026, and reference Solicitation Number 75N98027Q00033. Responses must be submitted electronically to Kevin Alvarez, Contracting Officer, kevin.alvarez@nih.gov. A determination by the Government whether to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered to determine whether to proceed on a non-competitive basis as indicated above, or to conduct a competitive procurement. Fax responses will not be accepted. | - | Special Notice | 10/29/2026 |
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith FAR Subpart 12.6, as supplemented with additional information included in thisnotice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00077. This solicitation is issued as a competitiveRequest for Quotation (RFQ) / combined synopsis/solicitation for commercial productsand commercial services using a Brand Name restriction in accordance with FAR 13.106-1(b)(1)(i). A Brand Name Justification is attached to this notice in accordance with FAR5.102(a)(6). This acquisition is conducted under the authority of FAR 12.603, StreamlinedSolicitation for Commercial Products or Commercial Services, in conjunction with FAR Part13 Simplified Acquisition Procedures, and is not expected to exceed the simplifiedacquisition threshold. The National Institutes of Health (NIH), Office of the Director, Officeof Acquisitions, seeks to award a Firm-Fixed-Price (FFP) Purchase Order to theresponsible offeror whose quotation represents the best value to the Government. (iii)The solicitation document and incorporated provisions and clauses are those in effectthrough Federal Acquisition Circular (FAC) number 2026-01 and effective date 03/13/2026. (iv)The associated NAICS code is 334516 (Analytical Laboratory InstrumentManufacturing), and the small business size standard is 1,000 employees. The ProductService Code (PSC) is 6640 (Laboratory Equipment and Supplies). [X]This requirement is set aside for Small Business concerns. | - | Combined Synopsis | 11/24/2026 |
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00072. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services restricted to the Brand Name specified herein in accordance with FAR 13.106-1(b)(1)(i). The Government intends to award a firm-fixed-price purchase order resulting from this solicitation using competition among the Original Equipment Manufacturer (OEM) and its authorized distributors. This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, on behalf of the National Heart, Lung, and Blood Institute (NHLBI), seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing), and the small business size standard is 1,000 employees. ¿ This requirement is unrestricted. (v) Description of Requirement: The National Heart, Lung, and Blood Institute (NHLBI), Laboratory of Advanced Microscopy and Biophotonics (LAMB), requires one (1) Brand Name Spectra-Physics (Newport Corporation / MKS Instruments) InSight® X3¿ Dual Ultrafast Laser System to integrate with an existing Thorlabs Veneto inverted multiphoton microscope for Fluorescence Lifetime Imaging Microscopy (FLIM) and Stimulated Raman Scattering (SRS) pump-probe experiments studying the effects of chemotherapeutic agents on cellular metabolism. | - | Combined Synopsis | 11/20/2026 |
Additional Details
Solicitation Number
75P00125Q00071
Archive Date
Oct 8, 2025
Office Address
ROCKVILLE, MD, 20857